作者:V. F. Mironov、B. I. Buzykin、R. S. Garaev、D. A. Tatarinov、L. R. Kashapov、R. V. Chestnova、V. N. Nabiullin、A. V. Il´yasov、V. V. Zobova
DOI:10.1007/s11172-014-0708-2
日期:2014.9
We studied some pharmacological properties of dimephosphone P—C and aza analogs, viz., dimethyl (2-methyl-4-oxopent-2-yl)phosphonate, which is one of the first organophosphorus drugs having no anticholinesterase activity. Replacement of two P—O—C fragments in dialkyl (2-methyl-4-oxopent-2-yl)phosphonates with the P—C ones on going to dialkyl-(2-methyl-4-oxopent-2-yl)phosphine oxides results in a dramatic
我们研究了二甲磷酮 P-C 和氮杂类似物的一些药理特性,即(2-甲基-4-氧代戊-2-基)膦酸二甲酯,它是最早的没有抗胆碱酯酶活性的有机磷药物之一。将 (2-甲基-4-氧代戊-2-基)膦酸二烷基酯中的两个 P-O-C 片段替换为二烷基-(2-甲基-4-氧代戊-2-基)膦的 P-C 片段氧化物导致后者对温血动物的急性毒性显着降低。研究中的二甲基膦氮杂类似物和(γ-氧代烷基)氧化膦的毒性取决于引入的氮杂片段而不是氧原子的性质。发现二甲基膦吡啶基腙表现出高抗炎活性,这增加了人们对这类化合物作为有前途的抑结核剂的兴趣。